Olivia Sutton

Chief Development Officer, CellResearch Therapeutics at CellResearch Corporation

Olivia currently serves as CellResearch’s Head of Projects where she plays a pivotal role in managing clinical development timelines for our lead asset: Corlicyte, as well as our pipeline indications.

Olivia has over 20 years of experience in the pharmaceutical industry in a range of project management roles. Olivia was previously Head Of PMO at Eirgen Pharma in Ireland supporting the development of several high potency value-added generic R&D developments for global markets, in addition to overseeing the technical transfer of products with a range of development partners. Before Eirgen, Olivia was Executive Director of Project Management at Mundipharma where she managed teams in the U.K., Singapore, China and Japan. Olivia is an experienced project leader and has a broad range of experience leading R&D developments from Phases I through to commercialization and market access in a range of therapeutic indications including pain, respiratory, immunological disorders, addiction and BPH, for markets across the EU, US, Asia Pacific and LATAM regions. During her time at Mundipharma, she successfully led several co-development with partner companies and academia and is highly experienced in leading virtual teams to success.

Previous to her time in project management Olivia worked in regulatory affairs with roles in industry and at the MHRA in London.

Olivia has an honors degree in biochemistry from the University of Surrey.